Neogenomics (NEO) Non-Current Assets (2010 - 2026)

Neogenomics (NEO) has reported Non-Current Assets for 17 consecutive years, with $972.8 million the latest figure, recorded in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $972.8 million, down 5.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $972.8 million (down 5.32% YoY), and the FY2025 annual result was $983.5 million, down 5.61% from the prior year.
• Non-Current Assets was $972.8 million for Q1 2026 at Neogenomics, down from $983.5 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $1.2 billion in Q1 2022 and troughed at $972.8 million in Q1 2026.
• Average Non-Current Assets over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2024.
• Year-over-year, Non-Current Assets jumped 113.61% in 2022 and dropped 5.61% in 2025.
• Over 5 years, Non-Current Assets stood at $1.1 billion in 2022, then slipped by 4.44% to $1.1 billion in 2023, then slipped by 3.91% to $1.0 billion in 2024, then dropped by 5.61% to $983.5 million in 2025, then retreated by 1.09% to $972.8 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $972.8 million in Q1 2026, $983.5 million in Q4 2025, and $992.3 million in Q3 2025.